Seems that BMY's IV dropped most on Roche news and further dropped this morning before MRK's news. IV's dropped >50% since 2 days ago for this week's options and dropped 1/3 for further expiries. Hindsight suggests tecentriq was the reason for nervousness re BMY.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.